5 terminated, 3 completed. 7 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Terminated 5, Completed 2 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow apaziquone: new trials by email Literature Review of apaziquone trials Research Report on apaziquone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Urinary Bladder Neoplasms (8) · Non-Muscle Invasive Bladder Neoplasms (4) · Carcinoma in Situ (1)
Spectrum Pharmaceuticals, Inc (7) · Nippon Kayaku Co., Ltd. (1)
United States (6) · Canada (2) · Poland (2) · Czechia (1) · Japan (1) · Netherlands (1) · Slovakia (1) · South Korea (1)
Shanta Chawla, MD (3) · Show-Li Sun, MD (2) · Alfred Witjes, MD, Prof. (1) · Kees Hendricksen, MD (1) · Woo Ick Jang, M.D., Ph.D. (1) · Yoshihiro Nambu, M.D., Ph.D. (1)